T. Kanamaru et al., BIOLOGICAL EFFECTS AND CELLULAR UPTAKE OF C-MYC ANTISENSE OLIGONUCLEOTIDES AND THEIR CATIONIC LIPOSOME COMPLEXES, Journal of drug targeting, 5(4), 1998, pp. 235
The biological effects and cellular uptake of human c-myc antisense ol
igonucleotides and their liposome complexes were investigated in vitro
using human promonocytic leukemia U937 cells. Antisense phosphorothio
ate oligonucleotides (S-Oligo) significantly inhibited the growth of U
937 cells in a dose-dependent manner. However, no significant effect o
n cell proliferation was observed with unmodified phosphodiester (P-Ol
igo) and partially phosphorothioated (PS3-Oligo) oligonucleotides with
an antisense sequence and S-Oligo with sense and G-quartet control se
quences. In cellular uptake experiments, radiolabeled S-Oligo was take
n up by U937 cells more than P-Oligo and PS3-Oligo, Similar results we
re obtained in mouse peritoneal macrophages used for comparison. Confo
cal microscopic studies demonstrated a significant distribution of FIT
C-labeled oligonucleotides on the cell surface and in the cytoplasm in
a punctate pattern, but not in the nucleus. When complexed with catio
nic liposomes, cellular uptake of FITC-labeled P-Oligo or S-Oligo was
significantly increased and the fluorescence was located mainly in the
nucleus, indicating that the uptake and intracellular pharmacokinetic
s of both oligonucleotides can be modified by complexation. An inhibit
ory effect of the complexes was observed at a dose which is ineffectiv
e in the case of the oligonucleotides alone. However, this effect was
also associated with cytotoxicity of the cationic liposomes, suggestin
g that optimization of this formulation will be necessary to achieve a
more efficient delivery of the oligonucleotides to U937 cells.